Android app on Google Play

Morgan Stanley Starts Cubist Pharmaceuticals (CBST) at Overweight

October 4, 2012 8:26 AM EDT Send to a Friend
Get Alerts CBST Hot Sheet
Price: $65.59 -1.44%

Rating Summary:
    11 Buy, 10 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 21 | Down: 25 | New: 14
Trade CBST Now!
Join SI Premium – FREE
Morgan Stanley initiates coverage on Cubist Pharmaceuticals (NASDAQ: CBST) with a Overweight. PT $68.00.

For an analyst ratings summary and ratings history on Cubist Pharmaceuticals click here. For more ratings news on Cubist Pharmaceuticals click here.

Shares of Cubist Pharmaceuticals closed at $48.48 yesterday.

You May Also Be Interested In

Related Categories

New Coverage

Related Entities

Morgan Stanley

Add Your Comment